alanyl-glutamyl-aspartyl-glycine has been researched along with Experimental Mammary Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anisimov, VN; Semenchenko, GV; Yashin, AI | 1 |
| Alimova, IN; Anisimov, VN; Bashurin, DA; Franceschi, C; Khavincon, BKh; Popovich, IG; Provinciali, M; Volkov, MA; Zabezhinskiĭ, MA | 1 |
2 other study(ies) available for alanyl-glutamyl-aspartyl-glycine and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Stressors and antistressors: how do they influence life span in HER-2/neu transgenic mice?
Topics: Animals; Dose-Response Relationship, Drug; Female; Genes, erbB-2; Longevity; Mammary Neoplasms, Experimental; Melatonin; Mice; Mice, Transgenic; Oligopeptides; Photic Stimulation; Sensory Deprivation; Sodium Chloride; Stress, Physiological; Survival Analysis | 2004 |
[Effect of Epitalon and Vilon treatment on mammary carcinogenesis in transgenic erbB-2/NEU mice].
Topics: Adenocarcinoma; Adjuvants, Immunologic; Animals; Dipeptides; Female; Genes, erbB-2; Mammary Neoplasms, Experimental; Mice; Mice, Transgenic; Oligopeptides | 2002 |